forty four In addition, anergic cells Ordinarily retain the next susceptibility to apoptosis Except anti-apoptotic proteins including BCL2 are overexpressed, as is the situation for CLL cells.forty five In fact, most main therapeutic innovations taking place in the final 10 years are connected with the inhibition of BCR and BCL2-mediated signaling.